Search

everythinglearnresearchcommunity

for

Search:↓

The "Danti Original Source" method can reverse androgenetic alopecia.

Social rejection can harm long-term mental health in transgender individuals.

The "exposure–crossover design" helps assess individual changes in risk after events like car crashes.

GnRH-a or orchiectomy is more effective than anti-androgens for managing hormone levels in transgender women.

Telogen effluvium is hair loss caused by disruption of the normal hair cycle.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Oocyte retrieval is possible for transgender men on testosterone therapy without affecting fertility outcomes.

Facial contouring is crucial for the satisfaction and well-being of Chinese transgender females.

Facial aesthetic procedures improve quality of life for transgender individuals.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

The observed "toughening" in keratin was actually due to water evaporation, not a real change in keratin.

The study concludes that as skin matures from infancy to childhood, there are major changes in cell differentiation, stemness, and growth, leading to a stronger skin barrier in older children.

Good communication helps predict successful aging in older Indonesians.

Understanding phenotypic plasticity is crucial for developing effective cancer therapies.

Fibroblast state switching is crucial for skin healing and development.

Parental support and gender-affirming care are crucial for the mental health of transgender adolescents.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Changes in early neurosteroid levels can affect adult learning and anxiety.

Hair transplants can help transgender individuals match their appearance with their gender identity.

The author suggests changing "telogen effluvium" to "telogen defluxion" for hair loss terminology.

Triphasic Progressive is more effective against hair loss.

Bilateral Orchiectomy effectively reduces the need for anti-androgen medication in most transgender females.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Wnt signaling is important for the change from the resting phase to the growth phase in human hair cycles.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Transgender patients on masculinizing hormones have higher hair loss rates than cisgender women.

Cyproterone acetate is a safe treatment that causes modest feminization in transgender female adolescents, and works better with added estrogens.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Transgender men on testosterone therapy need ongoing gynecologic care due to potential cancer risks.